<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>An Orbital Malignant Melanoma Arising in Cellular Blue Nevus in a Patient with Nevus of Ota.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="An Orbital Malignant Melanoma Arising in Cellular Blue Nevus in a Patient with Nevus of Ota." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039011/bin/cureus-0008-000000000698-i03.jpg"/> </div> <div class="text-side"> <h1>An Orbital Malignant Melanoma Arising in Cellular Blue Nevus in a Patient with Nevus of Ota.</h1> <p>Histopathology and Immunohistochemistry of Orbital MassA) (x10) The blue nevus component showing diagnostic pigmented spindle-shaped dendritic cells at left upper corner and adjacent amelanotic uniform oval to spindle cells with inconspicuous nucleoli and clear cytoplasm. B) (x10) Low power microscopic photo shows the benign blue nevus component (right) with an abrupt transition to distinctive malignant melanoma (left). C) (x40) Magnified benign component. D) (x40) Magnified malignant component shows pigmented melanocytes with prominent nucleoli, high nuclear to cytoplasmic ratio, and increased mitosis. E) (x10) Immunostain for HMB-45 shows both benign (right) and malignant (left) components that are strongly diffusely positive for HMB-45. F) (x10) Immunostain for p16 shows an abrupt distinction of benign (right) component with rare positive cells and a malignant component (left) with diffusely positive cells. G) (x10) Immunostain for MIB-1/Ki67 shows an abrupt distinction of benign (right) component with rare positive cells and malignant component (left) with a marked increase in proliferative index. A – D, hematoxylin and eosin.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27699140/" target="_blank">27699140</a></p><p>Type: Benign, Category: Melanocytic</p>
</div> </div></div></body></html>